We are live on
!
Find out more
NL
Navalign LLC Portfolio holdings
AUM
$429M
1-Year Est. Return
18.12%
This Quarter
Est. Return
+2.25%
1 Year Est. Return
+18.12%
3 Year Est. Return
+50.7%
5 Year Est. Return
+57.4%
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$28.4M
(+7.5%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
512
New
387
Increased
60
Reduced
39
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Quality Factor ETF
JQUA
|
+$7.59M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$2.39M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$839K |
| 4 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$789K |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$750K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$3.86M |
| 2 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$909K |
| 3 |
NVIDIA
NVDA
|
+$367K |
| 4 |
Eli Lilly
LLY
|
+$191K |
| 5 |
Broadcom
AVGO
|
+$188K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.55% |
| 2 | Healthcare | 5.47% |
| 3 | Financials | 4.88% |
| 4 | Communication Services | 3.64% |
| 5 | Industrials | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Unilever
UL
$136B
| $3.4K | ﹤0.01% |
+52
| New | +$3.5K |
|
402
Exelon
EXC
$47B
| $3.4K | ﹤0.01% |
+78
| New | +$3.56K |
|
403
Oshkosh
OSK
$9.59B
| $3.34K | ﹤0.01% |
+27
| New | +$3.47K |
|
404
Riot Platforms
RIOT
$7.76B
| $3.21K | ﹤0.01% |
+253
| New | +$4.33K |
|
405
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
| $3.1K | ﹤0.01% |
+20
| New | +$3.08K |
|
406
Haleon
HLN
$44.2B
| $3.08K | ﹤0.01% |
+305
| New | +$2.9K |
|
|
HDV
407
iShares Core High Dividend ETF
HDV
$14.8B
| $3.04K | ﹤0.01% |
+125
| New | +$3.04K |
|
408
Strategy Inc
MSTR
$38.4B
| $3.04K | ﹤0.01% |
+20
| New | +$4.6K |
|
409
Pacer US Cash Cows 100 ETF
COWZ
$19.4B
| $3.01K | ﹤0.01% |
+50
| New | +$2.94K |
|
410
First Majestic Silver
AG
$9.07B
| $2.98K | ﹤0.01% |
+179
| New | +$2.49K |
|
|
MRCC
411
DELISTED
Monroe Capital Corp
MRCC
| $2.87K | ﹤0.01% |
+450
| New | +$2.99K |
|
412
Halliburton
HAL
$26.6B
| $2.83K | ﹤0.01% |
+100
| New | +$2.64K |
|
413
Synopsys
SNPS
$79.7B
| $2.82K | ﹤0.01% |
+6
| New | +$2.67K |
|
414
Kinross Gold
KGC
$32.8B
| $2.82K | ﹤0.01% |
+100
| New | +$2.6K |
|
415
Iovance Biotherapeutics
IOVA
$2.87B
| $2.73K | ﹤0.01% |
+1,000
| New | +$2.31K |
|
416
Cirrus Logic
CRUS
$6.26B
| $2.73K | ﹤0.01% |
+23
| New | +$2.83K |
|
417
Truist Financial
TFC
$64B
| $2.64K | ﹤0.01% |
+54
| New | +$2.49K |
|
418
Dynatrace
DT
$14.2B
| $2.6K | ﹤0.01% |
+60
| New | +$2.8K |
|
419
Roblox
RBLX
$27B
| $2.43K | ﹤0.01% |
+30
| New | +$3.19K |
|
|
DPG
420
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
| $2.42K | ﹤0.01% |
+190
| New | +$2.47K |
|
421
Adient
ADNT
$1.5B
| $2.4K | ﹤0.01% |
+125
| New | +$2.63K |
|
422
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.85B
| $2.38K | ﹤0.01% |
+375
| New | +$11.3K |
|
423
First Solar
FSLR
$26.9B
| $2.35K | ﹤0.01% |
+9
| New | +$2.27K |
|
424
Estee Lauder
EL
$32B
| $2.3K | ﹤0.01% |
+22
| New | +$2.13K |
|
425
Veralto
VLTO
$24B
| $2.29K | ﹤0.01% |
+23
| New | +$2.33K |
|
Similar funds
BP
LJAF
CSNH
OA
RCWVOTCITCONY
MAM
GPGA
WPW
Navalign LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Navalign LLC held 512 positions worth $407M, up 7.5% from $379M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Navalign LLC deployed $21.5M of net new capital in Q4 2025, opening 387 new positions and adding to 60 existing holdings. Its largest new stake was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $3.86M trimmed.
- Navalign LLC's largest Q4 2025 buy was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
- Navalign LLC added most to Fidelity Total Bond ETF in Q4 2025, an estimated $2.39M increase.
- Navalign LLC's biggest Q4 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $3.86M.
- Navalign LLC fully exited Cue Biopharma in Q4 2025, selling an estimated $18K.
- Navalign LLC's ten largest holdings make up 53% of its $407M portfolio in Q4 2025.
- Navalign LLC opened 387 new positions and closed 1 in Q4 2025.
- Navalign LLC's portfolio value rose 7.5% quarter-over-quarter to $407M.
Based on Navalign LLC's 13F filing for Q4 2025, filed 5 Feb 2026.